NuVasive to provide up to $85m in investment to Progentix
This article was originally published in Clinica
Executive Summary
Spinal surgery specialist NuVasive is set to give its financial backing to Progentix Orthobiology, a Dutch firm focused on developing a synthetic bone substitute.